Elaine Caughey is Chief Business Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 18,986 shares of KYMR, which is worth approximately $825,511. The most recent transaction as insider was on Mar 02, 2023, when has been sold 714 shares (Common Stock) at a price of $31.14 per share, resulting in proceeds of $22,233. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19K
0% 3M change
0% 12M change
Total Value Held $825,511

Elaine Caughey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Open market or private sale
$22,233 $31.14 p/Share
714 Reduced 3.62%
18,986 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
10,557 Added 34.89%
19,700 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
7,000 Added 50.0%
7,000 Common Stock
EC

Elaine Caughey

Chief Business Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR